Line 91: | Line 91: | ||
<tr bgcolor= "#efefef"> | <tr bgcolor= "#efefef"> | ||
− | <td align="center"><h4>Romel Menacho- <br>Melgar</h4> | + | <td align="center"><h4>Romel Menacho-</h4> <br> <h4> Melgar </h4> |
<p><br>Romel is a Biomedical Engineering PhD student. Originally from Peru, he came to the US to the University of South Carolina to earn a BS degree in Biomedical Engineering in 2009. He started his graduate studies at Duke in 2013 and joined the Lynch Lab in 2015. His project involves developing a platform for in vivo peptide lipidation for novel materials and pharmaceuticals</p> | <p><br>Romel is a Biomedical Engineering PhD student. Originally from Peru, he came to the US to the University of South Carolina to earn a BS degree in Biomedical Engineering in 2009. He started his graduate studies at Duke in 2013 and joined the Lynch Lab in 2015. His project involves developing a platform for in vivo peptide lipidation for novel materials and pharmaceuticals</p> | ||
</td> | </td> |
Revision as of 21:34, 13 October 2018
Our Team
Daniel Getman
|
|
Maria Ter Weele
|
|
Adam Yaseen
|
|
Keng Zhang
|
|
Joe Choo-Choy
|
|
Trudy Zou
|
Our Advisors
Michael Lynch
|
|
Adim Moreb
|
|
John Decker
|
|
Romel Menacho-Melgar
|